Cerebrospinal Fluid Leak Management

Vaccination Recommendations

The Infectious Diseases Society of America recommends pneumococcal, meningococcal, and Haemophilus influenzae type b vaccinations for all patients with cerebrospinal fluid (CSF) leaks to reduce the risk of recurrent meningitis 1
The Centers for Disease Control and Prevention suggest administering pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine sequentially for patients with CSF leaks 1
Vaccination is beneficial in reducing the risk of recurrent meningitis in patients with CSF leaks, according to the Clinical Microbiology and Infection guidelines 2

The European Society of Clinical Microbiology and Infectious Diseases recommends empiric treatment with ceftriaxone 2g IV every 12 hours or cefotaxime 2g IV every 6 hours for suspected meningitis or meningococcal sepsis 3
For patients 60 years and older, or those who are immunocompromised, adding ampicillin or amoxicillin 2g IV every 4 hours is recommended to cover Listeria monocytogenes 3, 4

For Streptococcus pneumoniae, treatment with cefotaxime or ceftriaxone for 10-14 days is recommended, with adjustments based on susceptibility testing 5
For Neisseria meningitidis, treatment with ceftriaxone or cefotaxime for 5 days is recommended 5
For Haemophilus influenzae, treatment with ceftriaxone or cefotaxime for 10 days is recommended 5, 6

For gram-negative bacillary meningitis and CSF leak, intrathecal aminoglycosides may be considered in addition to systemic antibiotics, but this approach should only be used in consultation with an infectious disease specialist 4, 6
The treatment duration for meningitis can be shortened to 10 days if the pathogen is unknown and the patient shows significant improvement by day 10, according to the Journal of Infection guidelines 4, 6